A Randomized Phase III Study of Follow Up With or Without Adjuvant Gefitinib (Iressa) Following Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer.
Latest Information Update: 22 Dec 2021
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Dec 2021 This trial has been completed in Italy, according to European Clinical Trials Database
- 10 Oct 2020 This trial has been completed in United Kingdom, according to European Clinical Trials Database. (2009-12-02)
- 13 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.